105 related articles for article (PubMed ID: 29938194)
1. Erratum: Self-Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma.
Zhang Y; Wang F; Li M; Yu Z; Qi R; Ding J; Zhang Z; Chen X
Adv Sci (Weinh); 2018 Jun; 5(6):1800811. PubMed ID: 29938194
[TBL] [Abstract][Full Text] [Related]
2. Erratum: Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis: Erratum.
Li S; Zhang T; Xu W; Ding J; Yin F; Xu J; Sun W; Wang H; Sun M; Cai Z; Hua Y
Theranostics; 2020; 10(12):5530-5531. PubMed ID: 32373228
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum].
Int J Nanomedicine; 2021; 16():7859-7860. PubMed ID: 34880611
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery.
Wu H; Jin H; Wang C; Zhang Z; Ruan H; Sun L; Yang C; Li Y; Qin W; Wang C
ACS Appl Mater Interfaces; 2017 Mar; 9(11):9426-9436. PubMed ID: 28247750
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible nanogel derived from functionalized dextrin for targeted delivery of doxorubicin hydrochloride to MG 63 cancer cells.
Das D; Rameshbabu AP; Ghosh P; Patra P; Dhara S; Pal S
Carbohydr Polym; 2017 Sep; 171():27-38. PubMed ID: 28578964
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration.
Mao X; Cheng R; Zhang H; Bae J; Cheng L; Zhang L; Deng L; Cui W; Zhang Y; Santos HA; Sun X
Adv Sci (Weinh); 2019 Jul; 6(13):1901124. PubMed ID: 31380196
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Bruheim S; Xi Y; Ju J; Fodstad O
Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Circ-MALAT1 Functions as Both an mRNA Translation Brake and a microRNA Sponge to Promote Self-Renewal of Hepatocellular Cancer Stem Cells.
Chen L; Kong R; Wu C; Wang S; Liu Z; Liu S; Li S; Chen T; Mao C; Liu S
Adv Sci (Weinh); 2020 May; 7(9):2000890. PubMed ID: 32382492
[TBL] [Abstract][Full Text] [Related]
9. Erratum.
Sci Technol Adv Mater; 2016; 17(1):188. PubMed ID: 27889790
[TBL] [Abstract][Full Text] [Related]
10. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma.
Ma W; Yang L; Liu H; Chen P; Ren H; Ren P
Biochem Biophys Res Commun; 2020 Jan; 521(1):204-211. PubMed ID: 31640855
[TBL] [Abstract][Full Text] [Related]
11. Erratum to:
Pilot and Feasibility Studies
Pilot Feasibility Stud; 2017; 3():48. PubMed ID: 29123916
[TBL] [Abstract][Full Text] [Related]
12. Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicin.
Pratt CB; Champion JE; Senzer N; Green AA; Rao B; Douglass E; Meyer WE; Crom DB
Cancer; 1985 Oct; 56(8):1930-3. PubMed ID: 2992753
[TBL] [Abstract][Full Text] [Related]
13. Erratum for
Spinal Cord Ser Cases; 2016; 2():16019. PubMed ID: 31265710
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Publisher Correction to: Multiple articles in Food Science and Biotechnology.
Publisher
Food Sci Biotechnol; 2018 Aug; 27(4):1245. PubMed ID: 30265261
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Publisher Correction: articles initially published in wrong volume.
Cell Death Discov; 2019; 5():116. PubMed ID: 31312525
[TBL] [Abstract][Full Text] [Related]
16. Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.
Pettke A; Hotfilder M; Clemens D; Klco-Brosius S; Schaefer C; Potratz J; Dirksen U
Anticancer Drugs; 2016 Nov; 27(10):1001-10. PubMed ID: 27487911
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived osteosarcoma cells are resistant to methotrexate.
Dos Santos Cavalcanti A; Meohas W; Ribeiro GO; de Sá Lopes AC; Gholamin S; Razavi M; Hanae Kasai Brunswick T; Avan A; Matheus Guimarães JA; Leite Duarte ME; Kahn SA
PLoS One; 2017; 12(9):e0184891. PubMed ID: 28934267
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Ion Therapy: A Novel Strategy for Acute Myocardial Infarction.
Yi M; Li H; Wang X; Yan J; Gao L; He Y; Zhong X; Cai Y; Feng W; Wen Z; Wu C; Ou C; Chang J; Chen M
Adv Sci (Weinh); 2020 May; 7(10):2000544. PubMed ID: 32440490
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Data-Driven Materials Science: Status, Challenges, and Perspectives.
Himanen L; Geurts A; Foster AS; Rinke P
Adv Sci (Weinh); 2020 Jan; 7(2):1903667. PubMed ID: 31993299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
